SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability

December 06, 2023 11:30 PM AEDT | By Cision
Follow us on Google News:

CAMARILLO, Calif., Dec. 6, 2023 /PRNewswire/ -- SaniSure, a global player in single-use bioprocessing solutions (drug substance and drug product form & fill) and cell & gene therapy is proud to announce that it has been awarded the EcoVadis Silver Rating for its sustainability practices. This recognition places SaniSure in the top 25% of rated companies and endorses the company's strong commitment to sustainable operations.


EcoVadis is a trusted platform that assesses the environmental and social performance of companies across various industries worldwide. SaniSure's overall score of 60 positions the company ahead of nearly 80% of the biomanufacturing industry.

"This EcoVadis Silver Rating is a testament to our pursuit of environmentally responsible practices in the bioprocessing industry. We are proud of this achievement, which recognizes the progress we have made in recent years and our clear commitment to continue increasingly embedding sustainability in the way we run our business," said Steven Chevillotte, CEO at SaniSure.

The EcoVadis Silver Rating recognition highlights SaniSure's proactive efforts to reduce its environmental impact throughout its operations. The company is committed to implementing robust environmental social governance programs and is focused on achieving even higher sustainability targets in the future.

For more information about SaniSure's sustainability initiatives and practices, please visit


The Best Home a Drug Can Get® — SaniSure designs, develops, and manufactures single-use solutions for the bioprocessing and cell & gene therapy markets. The SaniSure portfolio includes customized bottle and container assemblies, low-volume mixing solutions, transfer sets, filling solutions, roller bottle systems, needles and needle assemblies, molded caps, flasks, tubing, bags, and clamps. With a global presence, SaniSure operates five facilities in North America and Europe, serving leading biopharma and biotech customers.



The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK